Phio Pharmaceuticals
PHIO
#10955
Rank
S$11.4 M
Marketcap
S$0.95
Share price
-3.99%
Change (1 day)
-44.33%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -S$16.63 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$11.22 Million a decrease over its 2024 earnings that were of -S$9.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$16.63 Million48.31%
2025 -S$11.22 Million21.65%
2024 -S$9.22 Million-33.96%
2023 -S$13.96 Million-5.7%
2022 -S$14.8 Million-13.6%
2021 -S$17.13 Million51.09%
2020 -S$11.34 Million-1.28%
2019 -S$11.49 Million21.03%
2018 -S$9.49 Million-53.1%
2017 -S$20.23 Million74.49%
2016 -S$11.6 Million-12.02%
2015 -S$13.18 Million16.17%
2014 -S$11.35 Million-57.95%
2013 -S$26.98 Million62.45%
2012 -S$16.61 Million0.87%
2011 -S$16.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 1,133.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.41 Million 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA